Effect of endothelin-1 receptor antagonists on histological and ultrastructural changes in the pancreas and trypsinogen activation in the early course of caerulein-induced acute pancreatitis in rats

Figure 3 Ultrastructural changes in the pancreatic acinar cells in caerulein-induced AP treated with non-selective (ET_A/B) or selective (ET_A) ET-1 receptors antagonists. A: Large vacuole (V) at the base of acinar cell opening into the interstitial space (IS). Group 3 – AP treated with LU 302872 (ET_A/B antagonist) at a dose of 10 mg/kg b.w. Original magnification ×4400, bar=1.7 μm; B: Irregular “lakes” of zymogen material (*), large vacuoles and zymogen granules at the base of two acinar cells. Group 3 – AP treated with LU 302872 (ETA/B antagonist) at a dose of 10 mg/kg b.w. Original magnification ×3000, bar=2.5 μm; C: Concentric arrangement, vesicular transformation and disorganization of endoplasmic reticulum. Note some phagosomes (Ph) in the cytoplasm. Group 4 – AP treated with LU 302872 (ET_A/B antagonist) at a dose of 20 mg/kg b.w. Original magnification ×3000, bar = 2.5 μm; D: Total disintegration of the acinar cell – its fragments in the interstitial space are seen. The endothelial cells (E) of capillary are swollen. Group 6 – caerulein-induced AP treated with LU 302146 (ET_A antagonist) at a dose of 20 mg/kg b.w. Original magnification ×3000, bar = 2.5 μm; E: Autophagous vacuoles containing zymogen granules, fragments of endoplasmic reticulum and other acinar cell organelles. Group 6 – caerulein-induced AP treated with LU 302146 (ET_A antagonist ) at a dose of 20 mg/kg b.w. Original magnification ×7000, bar = 1.1 μm.